NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Al4door, here is a very short reply to you. I have no interest in spending the next few days defending this as I am sure the naysayers will not let this go quietly. So take it or leave it but I do not wish to be drawn into a discussion on this reply in red below.

How many pump jobs has this company pulled off?

. Last Sep cancelling a presentation because they were awaiting the imminent publication that had not been submitted. Not a pump. They hoped the would get published quicker. There was never an NR stating that was the reason for the cancellation as I recall.

. Last ASCO, only 2 events to go [though they had no intent to unblind at 233] Perhaps not, but perhaps they had hoped that the pub would be out by then. No intention to unblind is only your assertion but they may have hoped to share more blinded info but couldn't.

. Dec '16, waiting on an event count [though not disclosing they were actually waiting on OS events] They do not make disclosures to please your curiosity.

. P2 Direct trial to start in 2015. Oh, and last ASCO Dr B confirmed summer 17. They had planned to start Direct back then but then events intervened like the halt then financing etc.

. IA in 2014 could lead to early halt [how the hell could anybody every argue 2014 while 2018 is not enough is beyond me] The IA debate is an old one and well discussed from both sides on this board. Just rehashing old arguments.

. UK PIMS, that they failed to disclose they never applied for the real step forward in the program They probably discovered that it would be quite expensive to continue with the PIMS app. so they dropped it hoping to pick it up ay a later time again when the economics made more sense.

. HE hospital exemption could lead to revenue. That was the hope that died on the difficulty of negotiating with the numerous parties in Germany.

. Prostate. This drug is now dead. If any real value they could have sold/partnered it I wondered that myself and assumed that they thought they could come back to it themselves when they had more financing and less on their plate.

. And of course, the Swiss approval. This too has been much discussed on this board and I believe Senti as I recall explained that fully. But as usual you keep rehashing all these old points over and over again.

The good news is that there is a large supply of greater fools to which longs can spin this too. Bad news is that the supply of shares is unlimited. And you end your post with a quick BASH to fit your agends.